| Identification | Back Directory | [Name]
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | [CAS]
853029-57-9 | [Synonyms]
Linaint-H
Linagliptin-1
Linagliptin Impurity 94
Linagliptin Impurity 32
Linagliptinmothernucleus
Iinagliptin Intermediate3
Linagliptin interMediate F
Linagliptin IntermediateLinagliptin Intermediate
1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl...
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)
8-bromo-7-(2-butyne)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-xanthine
1-[(4-Methylquinazolin-2-yl)Methyl]-3-Methyl-7-(2-butin-1-yl)-8-broMoxanthine
1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
8-bromo-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
8-BroMo-7-but-2-ynyl-3-Methyl-1-(4-Methyquinazolin-2-ylMethyl)-3,7-dihydro-purine-2,6-dione
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
8-broMo-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione
8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-d
8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquin-azolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dion
8-BroMo-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione
8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
1H-Purine-2,6-dione,8-broMo-7-(2-butynyl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-
8-BroMo-7-(2-butyn-a-yl)-3,7-dihydro-3-Methyl-1-[(4-Methyl-2-quinazolinyl)Methyl]-1H-purine-2,6-dione
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
1H-Purine-2,6-dione, 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-
8-BROMO-7-BUT-2-YNYL-3-METHYL-1-(4-METHYL-QUINAZOLIN-2-YLMETHYL)-3,7-DIHYDRO-PURINE-2,6-DIONE 853029-57-9
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione ISO 9001：2015 REACH
(2-(chloromethyl)-4-methylquinazoline)，8-Bromo-7-but-2-ynyl-3-methyl-1-(4- methyl-quinazolin-2-ylmethyl)-3,7- dihydro-purine-2,6-dione | [EINECS(EC#)]
922-028-0 | [Molecular Formula]
C20H17BrN6O2 | [MDL Number]
MFCD18642578 | [MOL File]
853029-57-9.mol | [Molecular Weight]
453.29 |
| Chemical Properties | Back Directory | [Melting point ]
>255°C (dec.) | [Boiling point ]
602.9±65.0 °C(Predicted) | [density ]
1.55 | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [solubility ]
DMSO (Slightly, Heated, Sonicated), Methanol (Very Slightly, Heated, Sonicated) | [form ]
Solid | [pka]
2.34±0.50(Predicted) | [color ]
White to Pale Yellow |
| Hazard Information | Back Directory | [Uses]
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione is an intermediate used to prepare selective inhibitors of dipeptidyl peptidase 4 (DPP4) for potential use in the treatment of type 2 diabetes. |
|
|